Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.8 USD | +0.53% | -0.21% | +11.79% |
Apr. 18 | Oppenheimer Adjusts Price Target on Xylem to $142 From $133, Outperform Rating Kept | MT |
Apr. 08 | ITT: From SME, to Conglomerate, to Specialization |
Financials (USD)
Sales 2024 * | 8.51B | Sales 2025 * | 8.97B | Capitalization | 30.91B |
---|---|---|---|---|---|
Net income 2024 * | 832M | Net income 2025 * | 994M | EV / Sales 2024 * | 3.72 x |
Net Debt 2024 * | 717M | Net Debt 2025 * | 105M | EV / Sales 2025 * | 3.46 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
31.9
x | Employees | 23,000 |
Yield 2024 * |
1.13% | Yield 2025 * |
1.2% | Free-Float | 93.17% |
Latest transcript on Xylem Inc.
1 day | +0.53% | ||
1 week | -0.21% | ||
Current month | -1.08% | ||
1 month | -0.47% | ||
3 months | +14.28% | ||
6 months | +38.72% | ||
Current year | +11.79% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Pine
CEO | Chief Executive Officer | 52 | 20-02-29 |
William Grogan
DFI | Director of Finance/CFO | 45 | 23-09-30 |
David Flinton
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Loranger
BRD | Director/Board Member | 72 | 11-10-30 |
Lisa Glatch
BRD | Director/Board Member | 61 | 23-05-23 |
Robert Friel
CHM | Chairman | 68 | 12-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.28% | 10 M€ | +6.14% | - | |
0.97% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 127.8 | +0.53% | 2,250,015 |
24-04-18 | 127.2 | +0.74% | 1,139,176 |
24-04-17 | 126.2 | -1.39% | 1,441,337 |
24-04-16 | 128 | +0.56% | 1,149,958 |
24-04-15 | 127.3 | -0.64% | 991,363 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.79% | 30.91B | |
+3.40% | 76.7B | |
+16.05% | 68.65B | |
+14.30% | 35.66B | |
+7.96% | 27.93B | |
+8.71% | 27.26B | |
+2.85% | 26.1B | |
+9.08% | 23.77B | |
+10.42% | 23.33B | |
+4.24% | 15.93B |
- Stock Market
- Equities
- XYL Stock